Evidence map›Paper›PMID 15673769›Full record

ArticleAntimicrobial agents and chemotherapy2005

Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.

Tadayoshi Ikebe, Kyoko Hirasawa, Rieko Suzuki, Junko Isobe, Daisuke Tanaka, Chihiro Katsukawa, Ryuji Kawahara, Masaaki Tomita, Kikuyo Ogata, Miyoko Endoh and 2 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Dihydrothiazolo ring-fused 2-pyridone antimicrobial compounds treatbioRxiv : the preprint server for biology · 2024
    Article
  5. In Silico Core Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors againstInternational journal of environmental research and public health · 2021
    Article
  6. Group AOman medical journal · 2021
    Review
  7. Biological Characterization and Inhibition ofMolecules (Basel, Switzerland) · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Global fluoroquinolone resistance epidemiology and implictions for clinical use.Interdisciplinary perspectives on infectious diseases · 2012
    Article
  12. Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2011
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tadayoshi IkebeDepartment of Bacteriology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Kyoko Hirasawa
Rieko Suzuki
Junko Isobe
Daisuke Tanaka
Chihiro Katsukawa
Ryuji Kawahara
Masaaki Tomita
Kikuyo Ogata
Miyoko Endoh
Rumi Okuno
Haruo Watanabe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assessed antimicrobial susceptibility against 211 Streptococcus pyogenes strains isolated from patients with severe invasive group A streptococcal infections. Overall, 3.8, 1.4, 1.4, and 0.5% of the isolates were resistant to erythromycin, clindamycin, telithromycin, and ciprofloxacin, respectively, and 10.4% had intermediate resistance to ciprofloxacin. All isolates were susceptible to ampicillin and cefotaxime.

Indexed as

Anti-Bacterial AgentsDeoxyribonucleases, Type II Site-SpecificDNA, BacterialDrug Resistance, BacterialElectrophoresis, Polyacrylamide GelErythromycinHumansJapanMicrobial Sensitivity TestsStreptococcal InfectionsStreptococcus pyogenesAnti-Bacterial AgentsCCCGGG-specific type II deoxyribonucleasesDeoxyribonucleases, Type II Site-SpecificDNA, BacterialErythromycin

Identifiers

PMID15673769
PMCPMC547282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.